Babson Diagnostics aims to democratize diagnostic blood testing by making it easier, faster, and more pleasant for customers to routinely monitor and improve their health. Babson's proprietary technological ecosystem is designed to deliver accurate diagnostic results with a more human experience. Based in Austin, Texas, its vision for diagnostic blood testing-built on accuracy, convenience, and accessibility-combines transformative diagnostic technology with a customer-first, retail-centric business model that aims to improve customer health and experience. Prior to commercialization, Babson Diagnostics is working with retail pharmacies to validate its technology by conducting clinical studies intended for peer-reviewed publication.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
09/24/20 | $13,700,000 | Series A |
Genesis Merchant Capital Lago Consulting Group Prism Ventures Siemens Healthineers | undisclosed |